IL102381A0 - Pharmaceutical compositions containing benzimidazoline-2-oxo-1-carboxylic acid derivatives for the treatment of organic mental diseases - Google Patents

Pharmaceutical compositions containing benzimidazoline-2-oxo-1-carboxylic acid derivatives for the treatment of organic mental diseases

Info

Publication number
IL102381A0
IL102381A0 IL102381A IL10238192A IL102381A0 IL 102381 A0 IL102381 A0 IL 102381A0 IL 102381 A IL102381 A IL 102381A IL 10238192 A IL10238192 A IL 10238192A IL 102381 A0 IL102381 A0 IL 102381A0
Authority
IL
Israel
Prior art keywords
benzimidazoline
oxo
treatment
carboxylic acid
pharmaceutical compositions
Prior art date
Application number
IL102381A
Other languages
English (en)
Original Assignee
Boehringer Ingelheim Italia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Italia filed Critical Boehringer Ingelheim Italia
Publication of IL102381A0 publication Critical patent/IL102381A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
IL102381A 1991-07-04 1992-07-02 Pharmaceutical compositions containing benzimidazoline-2-oxo-1-carboxylic acid derivatives for the treatment of organic mental diseases IL102381A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI911845A IT1250629B (it) 1991-07-04 1991-07-04 Uso dei derivati dell'acido benzimidazolin-2-oxo-1-carbossilico.

Publications (1)

Publication Number Publication Date
IL102381A0 true IL102381A0 (en) 1993-01-14

Family

ID=11360276

Family Applications (1)

Application Number Title Priority Date Filing Date
IL102381A IL102381A0 (en) 1991-07-04 1992-07-02 Pharmaceutical compositions containing benzimidazoline-2-oxo-1-carboxylic acid derivatives for the treatment of organic mental diseases

Country Status (17)

Country Link
EP (1) EP0523013B1 (zh)
JP (1) JPH05194216A (zh)
KR (1) KR930001906A (zh)
AT (1) ATE115857T1 (zh)
AU (1) AU658197B2 (zh)
CA (1) CA2072911A1 (zh)
DE (1) DE69200948T2 (zh)
DK (1) DK0523013T3 (zh)
GR (1) GR3015413T3 (zh)
HU (2) HUT61462A (zh)
IE (1) IE922174A1 (zh)
IL (1) IL102381A0 (zh)
IT (1) IT1250629B (zh)
MX (1) MX9203900A (zh)
NO (1) NO922635L (zh)
TW (1) TW202386B (zh)
ZA (1) ZA924949B (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05310732A (ja) * 1992-03-12 1993-11-22 Mitsubishi Kasei Corp シンノリン−3−カルボン酸誘導体
JP2699794B2 (ja) * 1992-03-12 1998-01-19 三菱化学株式会社 チエノ〔3,2−b〕ピリジン誘導体
WO2001042224A1 (en) * 1999-12-09 2001-06-14 Mitsubishi Pharma Corporation Carboxyamido derivatives
EP1861377B1 (en) * 2005-03-15 2010-12-29 Pfizer, Inc. Benzimidazolone derivatives as cb2 receptor ligands

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4605652A (en) * 1985-02-04 1986-08-12 A. H. Robins Company, Inc. Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido)-azabicycloalkanes
DE3752062T2 (de) * 1986-12-17 1997-09-11 Glaxo Group Ltd Verwendung von heterozyklischen Derivaten zur Herstellung von Arzneimitteln
IT1231413B (it) * 1987-09-23 1991-12-04 Angeli Inst Spa Derivati dell'acido benzimidazolin-2-osso-1-carbossilico utili come antagonisti dei recettori 5-ht
US4887422A (en) * 1988-09-06 1989-12-19 Amsted Industries Incorporated Rope with fiber core and method of forming same

Also Published As

Publication number Publication date
AU658197B2 (en) 1995-04-06
EP0523013A3 (en) 1993-01-27
TW202386B (zh) 1993-03-21
NO922635L (no) 1993-01-05
AU1938192A (en) 1993-01-07
ITMI911845A0 (it) 1991-07-04
ATE115857T1 (de) 1995-01-15
IT1250629B (it) 1995-04-21
HU211855A9 (en) 1995-12-28
HU9202229D0 (en) 1992-10-28
MX9203900A (es) 1993-01-01
GR3015413T3 (en) 1995-06-30
IE922174A1 (en) 1993-01-13
EP0523013B1 (en) 1994-12-21
ZA924949B (en) 1994-01-03
DE69200948D1 (de) 1995-02-02
DK0523013T3 (da) 1995-05-08
JPH05194216A (ja) 1993-08-03
KR930001906A (ko) 1993-02-22
CA2072911A1 (en) 1993-01-05
ITMI911845A1 (it) 1993-01-05
DE69200948T2 (de) 1995-05-18
EP0523013A2 (en) 1993-01-13
HUT61462A (en) 1993-01-28
NO922635D0 (no) 1992-07-03

Similar Documents

Publication Publication Date Title
ZA928170B (en) Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-D-neuraminic acid
AU637086B2 (en) Use of 5-methyltetrahydrofolic acid, 5-formyltetrahydrofolic acid and their pharmaceutically acceptable salts in the preparation of pharmaceutical compositions in controlled- release form active in the therapy of organic mental disturbances, and the relative pharmaceutical compositions
NZ240936A (en) Alkoxy-substituted 1-phenyl-isoquinoline derivative and pharmaceutical compositions
IL104006A0 (en) Azaheterocyclylmethyl-chromans,their preparation and pharmaceutical compositions containing them
IL109578A0 (en) Nor-bile acid derivatives, processes for their preparation and the use of these compounds as medicaments
CY2123B1 (en) Isoxazole-4-carboxamides and hydroxyalkylidene-cyanoacetamides drugs containing these compounds and use of such drugs
ZA885192B (en) Pharmaceutical preparations
NZ218028A (en) Benzimidazole derivatives and pharmaceutical compositions
IL94819A0 (en) 11beta-aryl-4-estrene derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
ZA881561B (en) Substituted pyridine-2,4-dicarboxylic acid derivatives,processes for their preparation,the use thereof and medicaments based on these compounds
GR3015413T3 (en) Use of benzimidazoline-2-oxo-1-carboxylic acid derivatives in the treatment of organic mental diseases.
EP0535250A4 (en) Novel compounds and use thereof as medicine
IL89335A (en) 6-oxo-pyridazine derivatives, a process for their preparation and pharmaceutical compositions containing these compounds
TW218011B (zh)
IL106289A (en) Phospholipid derivatives their preparation and pharmaceutical compositions containing them
NZ223333A (en) 3-phenyl-7h-thiazole (3,2-b (1,2, triazin-7-one derivatives and pharmaceutical compositions
NO163283C (no) Analogifremgangsm te til fremstilling av terapeutisk aktive n-bicykloheptyl og n-bicykloheptenylimidazoler.